Monthly Archives: June 2008

Crohn's Disease Drug Approved

The US Food and Drug Administration (FDA) has approved Tysabri (Natalizumab), a monoclonal antibody for the treatment of moderate to severe Crohn’s disease in patients with evidence of inflammation who have had an inadequate response to, or are unable to …

Read more »

A Chilli Gut Feeling

Sufferers of irritable bowel syndrome (IBS) apparently have more protein receptors for the active compounds in chilli peppers, according to a study to be published June 11 in the journal Gut (PDF). The findings might one day lead to new …

Read more »